As on Wednesday, Tango Therapeutics Inc (NASDAQ: TNGX) got off with the flyer as it spiked 3.56% to $8.28, before settling in for the price of $8.0 at the close. Taking a more long-term approach, TNGX posted a 52-week range of $1.03-$9.70.
It was noted that the giant of the Healthcare sector posted annual sales growth of 7.47% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 7.47%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.61%. This publicly-traded company’s shares outstanding now amounts to $111.57 million, simultaneously with a float of $79.24 million. The organization now has a market capitalization sitting at $1.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.92, while the 200-day Moving Average is $4.78.
Tango Therapeutics Inc (TNGX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Tango Therapeutics Inc’s current insider ownership accounts for 41.13%, in contrast to 72.60% institutional ownership. According to the most recent insider trade that took place on Oct 23 ’25, this organization’s 10% Owner sold 477,401 shares at the rate of 10.15, making the entire transaction reach 4,846,575 in total value, affecting insider ownership by 13,386,574.
Tango Therapeutics Inc (TNGX) Earnings and Revenue Records
Tango Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 26.61% and is forecasted to reach -1.24 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -5.06% through the next 5 years, which can be compared against the 7.47% growth it accomplished over the previous five years trading on the market.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Let’s observe the current performance indicators for Tango Therapeutics Inc (TNGX). It’s Quick Ratio in the last reported quarter now stands at 8.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.77.
In the same vein, TNGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.92, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.24 at the market close of one year from today.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Through scrutinizing the latest numbers posted by the [Tango Therapeutics Inc, TNGX], it can be observed that its last 5-days Average volume of 2.91 million was better the volume of 2.1 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 52.43% While, its Average True Range was 56.43.
Raw Stochastic average of Tango Therapeutics Inc (TNGX) in the period of the previous 100 days is set at 71.12%, which indicates a major rise in contrast to 66.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.65 that was higher than 0.55 volatility it exhibited in the past 100-days period.
